Potential beneficial effects of oral administration of isoflavones in patients with chronic mountain sickness

Experimental and Therapeutic Medicine
Jianhua CuiYuqi Gao

Abstract

Soy isoflavones (Ifs), which are natural phytoestrogens, have beneficial effects in cardiovascular disease. We have previously shown that genistein, the most active component of Ifs, inhibits pulmonary vascular structural remodeling and right ventricular hypertrophy induced by chronic hypoxia in male Wistar rats. This study aimed to evaluate the effects of Ifs on right ventricular and pulmonary hemodynamics in individuals with chronic mountain sickness (CMS). Twenty-eight male patients living on the Qinghai-Tibetan plateau (5,200 m) who were suffering from CMS were treated orally with Ifs (20 mg, twice daily) for 45 days. Physiological and plasma biochemical indices, hematology and echocardiography were investigated. It was observed that 45 days of treatment with Ifs significantly increased blood oxygen saturation and markedly decreased the CMS score and heart rate (all P<0.05) of the subjects. Following treatment with Ifs, hematocrit (P<0.05), hemoglobin concentration (P<0.01) and plasma levels of malondialdehyde (P<0.05) were significantly decreased, while plasma levels of nitric oxide (P<0.01) and the plasma activity of nitric oxide synthase (P<0.01) and superoxide dismutase (P<0.01) were markedly increased compared with the...Continue Reading

References

Oct 1, 1992·International Journal of Sports Medicine·C Monge-CF León-Velarde
Mar 7, 1996·The New England Journal of Medicine·U ScherrerP Bärtsch
Sep 27, 2000·The Journal of Nutritional Biochemistry·J LigginsS A Bingham
Sep 29, 2000·American Journal of Physiology. Heart and Circulatory Physiology·Y AllemannM Maggiorini
Mar 7, 2002·Lancet·Raul PlataUNKNOWN Commission on Global Advancement of Nephrology (COMGAN), Research Subcommittee of the International Society of Nephrology
May 1, 1996·Wilderness & Environmental Medicine·M VargasL Rey
Dec 16, 2003·High Altitude Medicine & Biology·Steve WoodMarlowe Eldridge
Jul 20, 2004·Journal of Applied Physiology·Tianyi WuZhigang Wang
Jul 19, 2005·Journal of Applied Physiology·Brian D HoitCynthia M Beall
Aug 3, 2005·High Altitude Medicine & Biology·Fabiola León-VelardeGustavo Zubieta-Calleja
Dec 15, 2005·High Altitude Medicine & Biology·Anjana G VijNarinder K Satija
Apr 5, 2008·American Journal of Respiratory and Critical Care Medicine·Jean-Paul RichaletFabiola León-Velarde
Mar 26, 2009·American Journal of Physiology. Endocrinology and Metabolism·Gustavo F GonzalesCynthia Gonzales-Castañeda
Jan 11, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Ri-Li GeBenjamin D Levine
Nov 11, 2011·Mini Reviews in Medicinal Chemistry·V B GencelR A Khalil
Jan 1, 1990·American Journal of Human Biology : the Official Journal of the Human Biology Council·Cynthia M BeallMario Barragan

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.